PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Klaeger, S.* ; Heinzlmeir, S.* ; Wilhelm, M.* ; Polzer, H.* ; Vick, B. ; Koenig, P.A.* ; Reinecke, M.* ; Ruprecht, B.* ; Petzoldt, S.* ; Meng, C.* ; Zecha, J.* ; Reiter, K.* ; Qiao, H.* ; Helm, D.* ; Koch, H.* ; Schoof, M.* ; Canevari, G.* ; Casale, E.* ; Depaolini, S.R.* ; Feuchtinger, A. ; Wu, Z.* ; Schmidt, T.* ; Rueckert, L.* ; Becker, W.* ; Huenges, J.* ; Garz, A.K.* ; Gohlke, B.O.* ; Zolg, D.P.* ; Kayser, G.* ; Vooder, T.* ; Preissner, R.* ; Hahne, H.* ; Tõnisson, N.* ; Kramer, K.* ; Götze, K.* ; Bassermann, F.* ; Schlegl, J.* ; Ehrlich, H.C.* ; Aiche, S.* ; Walch, A.K. ; Greif, P.A.* ; Schneider, S.* ; Felder, E.R.* ; Ruland, J.* ; Médard, G.* ; Jeremias, I. ; Spiekermann, K.* ; Kuster, B.*

The target landscape of clinical kinase drugs.

Science 358:eaan4368 (2017)
Verlagsversion Postprint Forschungsdaten DOI PMC
Open Access Green
Kinase inhibitors are important cancer therapeutics. Polypharmacology is commonly observed, requiring thorough target deconvolution to understand drug mechanism of action. Using chemical proteomics, we analyzed the target spectrum of 243 clinically evaluated kinase drugs. The data revealed previously unknown targets for established drugs, offered a perspective on the "druggable" kinome, highlighted (non)kinase off-targets, and suggested potential therapeutic applications. Integration of phosphoproteomic data refined drug-affected pathways, identified response markers, and strengthened rationale for combination treatments. We exemplify translational value by discovering SIK2 (salt-inducible kinase 2) inhibitors that modulate cytokine production in primary cells, by identifying drugs against the lung cancer survival marker MELK (maternal embryonic leucine zipper kinase), and by repurposing cabozantinib to treat FLT3-ITD-positive acute myeloid leukemia. This resource, available via the ProteomicsDB database, should facilitate basic, clinical, and drug discovery research and aid clinical decision-making.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
37.205
7.688
322
386
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Integrative Genomics Viewer; Salt-inducible Kinases; Chemical Proteomics; Inhibitor Selectivity; Comprehensive Analysis; Data Quality; Protein; Quantification; Refinement; Cancer
Sprache englisch
Veröffentlichungsjahr 2017
HGF-Berichtsjahr 2017
ISSN (print) / ISBN 0036-8075
e-ISSN 1095-9203
Zeitschrift Science
Quellenangaben Band: 358, Heft: 6367, Seiten: , Artikelnummer: eaan4368 Supplement: ,
Verlag American Association for the Advancement of Science (AAAS)
Verlagsort Washington
Begutachtungsstatus Peer reviewed
Institut(e) Research Unit Apoptosis in Hematopoietic Stem Cells (AHS)
CF Pathology & Tissue Analytics (CF-PTA)
Research Unit Analytical Pathology (AAP)
POF Topic(s) 30204 - Cell Programming and Repair
30505 - New Technologies for Biomedical Discoveries
30205 - Bioengineering and Digital Health
Forschungsfeld(er) Stem Cell and Neuroscience
Enabling and Novel Technologies
PSP-Element(e) G-506600-001
A-630600-001
G-500390-001
DOI 10.1126/science.aan4368
WOS ID WOS:000416584000032
Scopus ID 85036597195
PubMed ID 29191878
Erfassungsdatum 2017-12-04
[➜Korrektur melden]